Mangrove Partners Durect Corp Transaction History

Mangrove Partners

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$0.78 - $2.1 $991,840 - $2.67 Million	-1,271,591 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $1.97 Million - $2.31 Million	1,271,591	1,271,591 $2.25 Million

591K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $294M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.